Knowledge Enhancing and Enabling Platform (KEEP), is a comprehensive Solution for generating and integrating knowledge from clinical trials.

The KEEP aims to integrate and enhance clinical knowledge and enable model-based meta-analysis (MBMA).

It provides the capability to quickly and securely access, share, explore, and analyze comprehensive, integrated, up-to-date clinical efficacy and safety data to facilitate effective drug development.

WHAT IS KEEP?

KNOWLEDGE REPOSITORY OF CLINICAL TRIAL DATA

  • Most current publicly available trial data

  • Design, patient, and treatment characteristics

  • Biomarker, efficacy, and safety outcomes

  • Internal CSRs, patient level data (optional)

EXPLORATORY ANALYSIS PLATFORM

  • Multi-variable filtering and summary tables

  • Comparative time course plots

COMMUNICATION TOOL

  • Makes data tangible and accessible – interact, plot, summarize, in real time

  • Maps the competitive landscape - navigate competitor information

  • Stimulates ideas for impactful analysis

WHY KEEP?

ACCESS MULTIPLE DATABASES ON ONE PLATFORM

  • Cardiovascular, CNS, immunology, infectious diseases, oncology, metabolic diseases, pain

  • Literature databases as well as internal CSRs

COMMUNICATE CURRENT KNOWLEDGE FROM CLINICAL TRIALS

  • Present up-to-date data in a user-friendly web-based interface

  • Illustrate between-trial variability for a multitude of interventions and endpoints

FACILITATE MODEL-BASED META-ANALYSIS

  • Facilitating early go/no go decisions

  • Optimizing dose selections and study designs

  • Quantitative analysis of comparative efficacy and safety of competitive interventions

acop.jpg

Booth #1

20th to 23rd, 2019
Orlando, FL

Booth # 1838
November 3–6, 2019

San Antonio, Texas

Booth # 102

March 18th - 21st, 2020

Houston, TX

  • Facebook Social Icon
  • Twitter Social Icon
  • LinkedIn Social Icon

Alliances

About Us

Rudraya Support

Support Services
24x7 Technical Support

Copyright © 2007 - 2019 Rudraya Corporation. All Rights Reserved. Privacy Statement